Lee Min Jung, Choi Jong Hee, Kwon Tae Woo, Jo Hyo-Sung, Ha Yujeong, Nah Seung-Yeol, Cho Ik-Hyun
Department of Convergence Medical Science, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, USA.
J Ginseng Res. 2023 Sep;47(5):672-680. doi: 10.1016/j.jgr.2023.05.001. Epub 2023 May 15.
Korean Red Ginseng (KRG), the steamed root of , has pharmacological activities for immunological and neurodegenerative disorders. But, the role of KRGE in multiple sclerosis (MS) remains unclear.
To determine whether KRG extract (KRGE) could inhibit demyelination in corpus callosum (CC) of cuprizone (CPZ)-induced murine model of MS.
Male adult mice were fed with a standard chow diet or a chow diet supplemented with 0.2% (w/w) CPZ for six weeks to induce demyelination while were simultaneously administered with distilled water (DW) alone or KRGE-DW (0.004%, 0.02 and 0.1% of KRGE) by drinking.
Administration with KRGE-DW alleviated demyelination and oligodendrocyte degeneration associated with inhibition of infiltration and activation of resident microglia and monocyte-derived macrophages as well as downregulation of proinflammatory mediators in the CC of CPZ-fed mice. KRGE-DW also attenuated the level of infiltration of Th1 and Th17) cells, in line with inhibited mRNA expression of IFN-γ and IL-17, respectively, in the CC. These positive effects of KRGE-DW mitigated behavioral dysfunction based on elevated plus maze and the rotarod tests.
The results strongly suggest that KRGE-DW may inhibit CPZ-induced demyelination due to its oligodendroglial protective and anti-inflammatory activities by inhibiting infiltration/activation of immune cells. Thus, KRGE might have potential in therapeutic intervention for MS.
高丽参(KRG),即 的蒸制根,对免疫和神经退行性疾病具有药理活性。但是,KRGE在多发性硬化症(MS)中的作用仍不清楚。
确定高丽参提取物(KRGE)是否能抑制由硫酸铜(CPZ)诱导的MS小鼠模型胼胝体(CC)的脱髓鞘。
雄性成年小鼠喂食标准饲料或添加0.2%(w/w)CPZ的饲料六周以诱导脱髓鞘,同时通过饮水分别单独给予蒸馏水(DW)或KRGE-DW(KRGE的0.004%、0.02%和0.1%)。
给予KRGE-DW可减轻脱髓鞘和少突胶质细胞变性,这与抑制常驻小胶质细胞和单核细胞衍生巨噬细胞的浸润和激活以及CPZ喂养小鼠CC中促炎介质的下调有关。KRGE-DW还减弱了Th1和Th17细胞的浸润水平,这分别与CC中IFN-γ和IL-17的mRNA表达受抑制一致。KRGE-DW的这些积极作用减轻了基于高架十字迷宫和转棒试验的行为功能障碍。
结果强烈表明,KRGE-DW可能因其对少突胶质细胞的保护和抗炎活性,通过抑制免疫细胞的浸润/激活而抑制CPZ诱导的脱髓鞘。因此,KRGE可能对MS的治疗干预具有潜力。